| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 289922 | Phosphonium, triphenyl-1-propenyl-, bromide, (E)- (9CI) | 0.00313644776247642 | 0.22137535 |
| NSC 624659 | ANTINEOPLASTIC-624659 | 0.00313644776247642 | 0.38819038 |
| NSC 625505 | Null | 0.00313644776247642 | 0.21884509 |
| NSC 666667 | Null | 0.00347157511980527 | 0.19989335 |
| NSC 709341 | Null | 0.00347157511980527 | -0.10666316 |
| NSC 132791 | Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo | 0.00397405528023193 | -0.054150284 |
| NSC 149765 | 1,4-Pentanediamine, N4-(6-methoxy-8-quinolinyl)-, phosphate (1:2) (9CI) | 0.00397405528023193 | -0.010261842 |
| NSC 616960 | 2[5H]-Furanone, 5-[(.beta.-D-glucopyranosyloxy)methyl]-,(S)- (9CI) | 0.00397405528023193 | 0.20807679 |
| NSC 625624 | 7,12-Epidioxybenz[a]anthracene, 7,12-dihydro-7-methyl- | 0.00397405528023193 | 0.38512518 |
| NSC 682769 | 5H-Pyrido[3,2-d][2]benzazepin-6(7H)-one, 4-(3,4-dimethoxyphenyl)-2-phenyl- | 0.00397405528023193 | -0.20891033 |